This altered glucose metabolism, which enhances biosynthetic fluxes and antioxidant defense during rapid proliferation of cancer cells, is regulated by transcription factors (TFs) such as the hypoxia inducible factor 1 alpha (HIF-1α) that activates either glycolytic enzymes or glucose and lactate transporters while inhibiting OXPHOS [8,9]. Here, HIF1A is linked to cancer.